Answers are grounded in this paper and cite their sources.
Using in vivo microfocus computed tomography (micro-CT) and tissue sections, we evaluated bone regeneration in non-critical-sized rat calvarial flat bone defects during systemic administration of lactoferrin (LF). Ten 11-week-old male Fischer rats were used. Non-critical-sized calvarial bone defects (diameter, 2.7 mm) were trephined into the dorsal parietal bone on both sides of the midsagittal suture, and a collagen sponge soaked in saline was placed on each side. LF was injected intraperitoneally every day, starting on the day of the operation (day 0; groups: control, 10 mg/kg LF, 100 mg/kg LF). Micro-CT imaging was performed repeatedly from 1 to 4 weeks after surgery. The defect sites were then removed, along with surrounding bone and soft tissues, and stained with hematoxylin and eosin. During weeks 1-4, micro-CT showed a significant difference in reossification ratio between the controls and the 100 mg/kg LF group. Histological analysis revealed that there were more osteoblast-like cells around the bony rim in the 100 mg/kg group than in the control group. In summary, micro-CT and histological analyses showed that systemic administration of LF accelerated bone regeneration in non-critical-sized rat calvarial bone defects.
No takes yet. Share an insight, caveat, or question.
Yoshimaki et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: